Grogan William K 4
Research Summary
AI-generated summary
Xylem (XYL) CFO William Grogan Receives Stock Awards and Option Grant
What Happened
- William K. Grogan, CFO of Xylem (XYL), received multiple equity awards and an option grant in early March 2026. On 2026-03-01/03-02 he was credited with vested performance-based shares (5,551; 4,583; 3,117) and an award of 5,116 restricted stock units, and was granted 18,228 non-qualified stock options.
- Reported values: the performance-share vestings are reported at $128.98 per share (5,551 = $715,968; 4,583 = $591,115; 3,117 = $402,031). The option grant (18,228) is reported at $128.98/share = $2,351,047. One award of 5,116 shares was reported at $0 (see footnotes re: dividend reinvestment/RSU schedule).
- To cover tax liabilities, 5,888 and 578 shares were withheld (reported as dispositions) at $128.98 each (total withheld value $759,434 + $74,550 = $833,984). Most activity is coded as A = award/grant; F = payment of tax liability (withholding).
Key Details
- Transaction dates and reported prices: 2026-03-01 and 2026-03-02; price used in report $128.98 per share for valuing awards and withholdings (one RSU line reported at $0).
- Total reported grant/vesting value: ~$4,060,161 (sum of reported acquisition values). Tax-withholding shares totaled 6,466 shares ($833,984), leaving net value retained per the report of roughly $3.23M.
- Shares owned after the transactions: Not provided in the supplied filing details.
- Notable footnotes: PSUs vested for Total Shareholder Return, Adjusted EBITDA, and Revenue (F1–F4); dividend reinvestment included additional shares (F2); RSUs and NQSO grants vest in one‑third increments on March 1, 2027/2028/2029 (F5, F8); withheld shares paid tax liabilities (F6, F7).
- Filing timing: Form 4 was filed 2026-03-03 reporting activity through 2026-03-02; this appears to be timely (filed within the SEC’s short reporting window).
Context
- These are company awards and option grants (A) and tax-withholding disposals (F), not open‑market purchases or opportunistic sales. Awards and option grants are common components of executive compensation and often follow multi-year performance/vesting schedules.
- The 18,228-item entry is a grant of non‑qualified stock options (derivative award) subject to future vesting; it does not represent immediately tradable shares unless/after options vest and are exercised.
- Tax-withholding via share retention is routine and should not be read as an active “sale” decision for liquidity or sentiment signals.